USPTO serial 85830300
ACTAVIS PHARMA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SNAPP, TINA LOUISE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ACTAVIS PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Hafnarfjordur 220, IS
PARSIPPANY, NJ
PARSIPPANY, NJ
PARSIPPANY, NJ
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gabrielle S. Roth
GABRIELLE S ROTH SUGHRUE MION PLLC2100 PENNSYLVANIA AVE NWWASHINGTON, DC 20037-3213UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science, namely, active chemical ingredients for use in the manufacture of pharmaceuticals, chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; chemical preparations for use in industry | ACTIVE | — |
| 003 | Soaps, perfumery, essential oils, cosmetics, namely, cosmetic preparations for skin care, cosmetic preparations for body care, cosmetic preparations for bath and shower, cosmetic creams, lotions, and ointments and gels for skin care, cosmetic skin fresheners and toners, cosmetic preparations for the hair and scalp, and hair lotions; dentifrices, namely, anti-cavity dental rinses, mouth rinses and mouth washes; cosmetic preparations for the care of mouth and teeth; skin and hair care preparations not for medical use | ACTIVE | — |
| 005 | Pharmaceuticals, namely, preparations and substances for the prevention and treatment of alimentary tract and metabolic diseases and disorders, dermatological diseases and disorders, genito-urinary and sexual diseases and disorders, musculo-skeletal system diseases and disorders, nervous system diseases and disorders, respiratory system diseases and disorders, cardio-vascular diseases and disorders specifically excluding tissue plasminogen activators, sensory organ diseases and disorders, systemic hormonal pharmaceutical preparations and substances, pharmaceuticals, namely, anti-infectives, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, antiparasitic preparations and substances; contraceptives; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations, pharmaceutical preparations and substances for the treatment of premenstrual syndrome, post natal depression, fluctuating hormone levels, pharmaceutical preparations and substances for infertility disorders, pharmaceutical preparations and substances for in vitro fertilization (ivf); pharmaceutical preparations in the nature of medicated dental rinses, mouth rinses, mouthwashes, dental lozenges, dental tablets and medicated chewing gum; dental wax; pharmaceutical preparations in the nature of pregnancy test kits, ovulation test kits and in-vitro ovulation prediction test kits all for home use; pharmaceutical preparations in the nature of diagnostic test kits for home use for detecting urinary tract infections, for detecting menopause, for detecting vaginal pH balances and for detecting sexually-transmitted diseases; pharmaceutical preparations for skin care; all the foregoing specifically excluding tissue plasminogen activators | ACTIVE | — |
| 041 | Educational services, namely, conducting conferences, seminars, webinars, video case studies, classes and workshops in the fields of healthcare, women's health, pharmaceuticals and medicine, pharmaceutical research and development | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Actavis Group PTC ehf
- Other trademarks owned by ACTAVIS, INC.
- Other trademarks owned by ACTAVIS, INC.
- Other trademarks owned by ACTAVIS HOLDCO US, INC.
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 041
- Similar marks named ACTAVIS PHARMA
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 9, 2018 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 9, 2018 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 19, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 18, 2017 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Sep 5, 2017 | EXT5 | SOU EXTENSION 5 FILED | — |
| Sep 5, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 7, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 3, 2017 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Mar 3, 2017 | EXT4 | SOU EXTENSION 4 FILED | — |
| Mar 3, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 22, 2017 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Sep 14, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 13, 2016 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Sep 6, 2016 | EXT3 | SOU EXTENSION 3 FILED | — |
| Sep 6, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 12, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 11, 2016 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 10, 2016 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 9, 2016 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 9, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 26, 2015 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 24, 2015 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 24, 2015 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 24, 2015 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 3, 2015 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 20, 2015 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Jan 20, 2015 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Jan 6, 2015 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Jul 31, 2014 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Jul 18, 2014 | UNDN | UNDELIVERABLE MAIL - NO ACTION TAKEN | — |
| Feb 27, 2014 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Feb 4, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 4, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 15, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 28, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 27, 2013 | ALIE | ASSIGNED TO LIE | — |
| Dec 3, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 3, 2013 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 3, 2013 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 3, 2013 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 3, 2013 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 24, 2013 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 24, 2013 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 24, 2013 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 4, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 4, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 4, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 30, 2013 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 30, 2013 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 14, 2013 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 14, 2013 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 14, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 20, 2013 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jan 29, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 26, 2013 | NWAP | NEW APPLICATION ENTERED | — |